Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 197

The DOI matches its Crossref record.

Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study

Open access
Wilde, Arthur A.M., Moss, Arthur J., Kaufman, Elizabeth S., Shimizu, Wataru, Peterson, Derick R., Benhorin, Jesaia, Lopes, Coeli, Towbin, Jeffrey A., Spazzolini, Carla, Crotti, Lia, Zareba, Wojciech, Goldenberg, Ilan, Kanters, Jørgen K., Robinson, Jennifer L., Qi, Ming, Hofman, Nynke, Tester, David J., Bezzina, Connie R., Alders, Marielle, Aiba, Takeshi, Kamakura, Shiro, Miyamoto, Yoshihiro, Andrews, Mark L., McNitt, Scott, Polonsky, Bronislava, Schwartz, Peter J., Ackerman, Michael J. · 2016 · Circulation

Abstract

Background: Risk stratification in patients with type 3 long-QT syndrome (LQT3) by clinical and genetic characteristics and effectiveness of β-blocker therapy has not been studied previously in a large LQT3 population. Methods: The study population included 406 LQT3 patients with 51 sodium channel mutations; 391 patients were known to be event free during the first year of life and were the focus of our study. Clinical, electrocardiographic, and genetic parameters were acquired for patients from 7 participating LQT3 registries. Cox regression analysis was used to evaluate the independent contribution of clinical, genetic, and therapeutic factors to the first occurrence of time-dependent cardiac events (CEs) from age 1 to 41 years. Results: Of the 391 patients, 118 (41 males, 77 females) patients (30%) experienced at least 1 CE (syncope, aborted cardiac arrest, or long-QT syndrome–related sudden death), and 24 (20%) suffered from LQT3-related aborted cardiac arrest/sudden death. The risk of a first CE was directly related to the degree of QTc prolongation. Cox regression analysis revealed that time-dependent β-blocker therapy was associated with an 83% reduction in CEs in females ( P =0.015) but not in males (who had many fewer events), with a significant sex × β-blocker interaction ( P =0.04). Each 10-ms increase in QTc duration up to 500 ms was associated with a 19% increase in CEs. Prior syncope doubled the risk for life-threatening events ( P <0.02). Conclusions: Prolonged QTc and syncope predispose patients with LQT3 to life-threatening CEs. However, β-blocker therapy reduces this risk in females; efficacy in males could not be determined conclusively because of the low number of events.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.116.021823

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 197

Metadata

Authors
Wilde, A. A. M., Moss, A. J., Kaufman, E. S., Shimizu, W., Peterson, D. R., Benhorin, J., Lopes, C., Towbin, J. A., Spazzolini, C., Crotti, L., Zareba, W., Goldenberg, I., Kanters, J. K., Robinson, J. L., Qi, M., Hofman, N., Tester, D. J., Bezzina, C. R., Alders, M., Aiba, T., Kamakura, S., Miyamoto, Y., Andrews, M. L., McNitt, S., Polonsky, B., Schwartz, P. J., & Ackerman, M. J.
Venue
Circulation
Published
2016-09-20
Volume
134
Issue
12
Pages
872-882
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2511790442
Cited by
197
References
0
FWCI
20.42
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study. https://app.cochat.ai/papers/10.1161/circulationaha.116.021823
The paper
Wilde, A. A. M., Moss, A. J., Kaufman, E. S., Shimizu, W., Peterson, D. R., Benhorin, J., Lopes, C., Towbin, J. A., Spazzolini, C., Crotti, L., Zareba, W., Goldenberg, I., Kanters, J. K., Robinson, J. L., Qi, M., Hofman, N., Tester, D. J., Bezzina, C. R., Alders, M., . . . Ackerman, M. J. (2016). Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study. Circulation. https://doi.org/10.1161/circulationaha.116.021823

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.